Moneycontrol PRO
HomeNewsBusinessIndia and US should work together in areas of pandemic preparedness, clinical trials: Balram Bhargava

India and US should work together in areas of pandemic preparedness, clinical trials: Balram Bhargava

The Indian government is taking the opportunity to develop the health care system in every way.

October 06, 2021 / 22:43 IST
(Representative image: Reuters)

India and the US should work together in areas of pandemic preparedness and bilateral clinical trials, said Balram Bhargava, Director-General of Indian Council of Medical Research.

Speaking at the India Ideas Summit, organised by United States India Business Council, Bhargava said that bilateral clinical trials will be more cost effective and that the two countries can work in areas of capacity building for health and non-communicable diseases.

Commenting on the takeaways from the Covid-19 pandemic, Bhargava noted that the Indian government is taking the opportunity to develop the health care system in every way.

Bhargava further said the government is working very hard to tackle the pandemic. The country administered 920 million doses of vaccines and conducted 600 million COVID tests in 18 months.

"India has realised that there is a capability which is a latent capability, which has to be unleashed," Bhargava said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

He said that India and the US should utilise their collaboration for the benefit of the countries.

"We together can contribute in bringing new technologies at a lower cost and scaling it up and helping in capacity building and training people in the region together, so that it will benefit mankind as a whole," Bhargava said.

He also said that the government has realised health is a very important sector, and therefore Ayushman Bharath and National Digital Health Mission have been launched.

Ayushman Bharat and National Digital Health Mission are going to be huge opportunities for key players from the US to manufacture in India.

"Investment by US companies manufacturing medical devices and diagnostics in India will ensure that the entire Far East and the African market can be taken care of with low investment," said Bhargava.

Commenting on the recently launched National Digital Health Mission, Bhargava said maintaining digital health records of 1.4 billion population could be a challenge.

However, having managed a large amount of data through the Cowin app, India can handle large volumes of data, he observed.

Shreeja Singh
first published: Oct 6, 2021 10:42 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
CloseOutskill Genai